Ritonavir: Difference between revisions
imported>David E. Volk No edit summary |
imported>Caesar Schinas m (Bot: Replacing medical templates with CZMed) |
||
Line 26: | Line 26: | ||
== External Links == | == External Links == | ||
{{CZMed}} | |||
Revision as of 01:25, 3 June 2009
| |||||||
ritonavir | |||||||
| |||||||
Uses: | HIV | ||||||
Properties: | protease inhibitor | ||||||
Hazards: | see drug interactions | ||||||
|
Ritonavir, sold under the brand names Norvir® and Norvir Sec®, and as a mixture with Lopinavir called Kaletra®, is a protease inhibitor used to treat HIV/AIDS by disrupting the reproductive cycle of the virus. Ritonavir binds to and inhibits the HIV-1 viral proteinase enzyme which prevents cleavage of the gag-pol polyprotein, resulting in noninfectious, immature viral particles. Protease inhibitors like ritonavir are almost always used in combination with at least two other anti-HIV drugs.
Chemistry
Its chemical name is 1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan- 2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-di(phenyl)hexan- 2-yl]carbamate and its chemical formula is C37H48N6O5S2.
External Links
The most up-to-date information about Ritonavir and other drugs can be found at the following sites.
- Ritonavir - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Ritonavir - Drug information for consumers from MedlinePlus (U.S. National Library of Medicine).
- Ritonavir - Detailed information from DrugBank.